Progyny, Inc.
Progyny, Inc. provides employer-sponsored fertility, family building, and women’s health benefits in the United States. Its platform combines benefit plan design, member education and care navigation, a selective provider network, and an integrated pharmacy benefits solution called Progyny Rx.
Fiscal year 2025 · change from previous year
Development 2020–2025
Business
Share of revenueEmployer-sponsored fertility coverage, care management, and member support for treatment journeys.
Integrated pharmacy benefits and medication support tied to fertility treatment.
Digital and concierge support across pregnancy, postpartum, menopause, and related milestones.
Products
Reported · share of revenue- Fertility Benefit Services64.5 %
- Pharmacy Benefit Services35.5 %
Source: 10-K FY2025, revenue the company reports per product line (SEC XBRL). Shares are of the lines shown and add up to 100 %.
Customers
Progyny sells primarily to U.S. employers that sponsor health benefits for large employee populations. These clients buy the service to improve access to fertility and women’s health care, support employee experience, and manage complex treatment pathways through a single benefits platform.
Employers with at least 1,000 covered lives that purchase fertility and women’s health benefits for their workforce.
Members who use fertility, pregnancy, postpartum, menopause, and navigation services through employer-sponsored coverage.
Intermediaries that help introduce Progyny to employer buyers and support sales conversion.
Partners that support network access, medication fulfillment, and integration with client benefit programs.
Strategy
Progyny’s strategy centers on expanding its employer client base, broadening the women’s health continuum, and deepening the value of its integrated fertility and pharmacy offering. It also emphasizes network management, member support, and data-driven care design to improve outcomes and reinforce its position with large employers and benefits consultants.
More clients and covered lives expand the installed base and support recurring benefit adoption.
Adding adjacent services increases wallet share and makes the platform more relevant across life stages.
Tighter coordination between treatment, authorization, and medication support can improve outcomes and retention.
Geography
Progyny’s business is concentrated in the United States, where it serves employers across more than 40 industries. Its operating model depends on access to U.S. providers, specialty pharmacies, and employer benefit channels, while treatment location and provider network design can affect service delivery economics.
Risks
Progyny depends on employer sales, third-party partners, and specialty pharmacy networks, so disruptions in any of those relationships can slow growth or impair service delivery. It also operates in a heavily regulated healthcare environment where communications rules, PBM oversight, and reimbursement or authorization practices can affect operations and compliance.
- Dependence on third-party relationshipsImpact: HighLikelihood: Medium
The business relies on channel partners, vendors, insurers, and specialty pharmacies to sell and deliver services.
Exposure - Specialty pharmacy network disruptionImpact: HighLikelihood: Medium
Progyny Rx depends on efficient medication distribution and supply chain continuity.
Exposure: Medication access and treatment continuity
- Healthcare and PBM regulationImpact: MediumLikelihood: Medium
The company is subject to increasing scrutiny around communications, benefits administration, and PBM operations.
Exposure - Guidance and expectation riskImpact: MediumLikelihood: Medium
Market valuation can be sensitive to whether operating results meet public expectations.
Exposure: Share price volatility
- Client concentration in large employersImpact: MediumLikelihood: Low
The model depends on retaining and expanding relationships with large employer accounts.
Exposure: Renewals and revenue stability
Accounting
Judgemental itemsA portion of revenue depends on estimates tied to member utilization and service delivery timing.
Impact: Can shift revenue between periods and affect reported growth
Healthcare service and pharmacy-related obligations require estimates of unpaid claims and related costs.
Impact: Affects cost of services and liabilities
Equity awards are a significant operating expense and can be volatile with hiring and grant activity.
Impact: Impacts operating margin and adjusted earnings reconciliation
Tax provisions depend on estimates and can vary with profitability and discrete items.
Impact: Affects net income and effective tax rate
Similar listed companies
Publicly listed companies with a comparable business focus.
Precigen, Inc
PGEN · Pharmaceutical Preparations
Doximity, Inc.
DOCS · Services-Computer Programming Services
Doximity is a digital platform for U.S.
ProAssurance Corporation
Fire, Marine & Casualty Insurance
Femasys Inc
FEMY · Surgical & Medical Instruments & Apparatus
Organon & Co.
OGN · Pharmaceutical Preparations
Pfizer, Inc
PFE · Pharmaceutical Preparations
Last updated: 24/09/2026